A
A
Home
About Us
History
Investors
Management
Board of Directors
Scientific Advisory Board
Product Pipeline
Technology
Antibodies Overview
Market
Intellectual Property
Glossary
Partnering
Press Room
Career
Contact
Maps & Directions Basel Site
Maps & Directions Jena Site
Impressum
Investors
Latest News
November 8th 2007
Don Drakeman joins
4-Antibody
Board
January 15th 2007
4-Antibody AG closes CHF 17 Million Series A, bringing the total Series A financing to CHF 23 Million ($18.5 Million)
August 21st 2006
4-Antibody AG closes CHF 6 Million Series A financing and appoints Sijmen de Vries as CEO